West Pharmaceutical extends butyl polymer supply agreement with ExxonMobil through 2028

WEST PHARMACEUTICAL SERVICES INC

Amendment secures supply of butyl polymers, a key raw material for pharmaceutical packaging, from 2024 to 2028.
Pricing includes base price plus adjustments based on Brent crude, UK natural gas, and USGC isobutylene indices (redacted).
Product qualification at Baton Rouge plant waives isobutylene adjustment during contract term as incentive.
New sustainability collaboration provision added, with joint discussions on activities and milestones.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

WEST PHARMACEUTICAL SERVICES INC amended global master supply agreement with ExxonMobil Product Solutions Company (effective 2023-11-27).

Action: amendment
Agreement: supply
Counterparty: ExxonMobil Product Solutions Company
Effective: 2023-11-27

Exact text from the filing

On November 27, 2023, West Pharmaceutical Services, Inc. (the “Company”) executed an amendment to the global master supply agreement (the “Amendment”) with ExxonMobil Product Solutions Company (“EMPSC”).

View on SEC.gov

629 material agreements filed in the last 30 days. Browse all material agreements →

WEST PHARMACEUTICAL SERVICES INC filing history →

Source: SEC EDGAR

accession 0000105770-23-000075

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.